HIGHLIGHTS
- who: Zhuo Shao from the (UNIVERSITY) have published the article: ZNF655 accelerates progression of pancreatic cancer by promoting the binding of E2F1 and CDK1, in the Journal: (JOURNAL) of 22/07/2021
- what: 2 At present study, the authors evaluated the expression level, biological function and underlying mechanisms of ZNF655 in human pancreatic cancer. The authors found that that malignant progression of ZNF655 knockdown pancreatic cancer cells was significantly inhibited, which was characterized by weaken proliferation, impeded migration, arrested cell cycle in G2 and enhanced apoptosis. Given that apoptosis is one of the biological phenotypes . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.